Ketamine Completed Phase 4 Trials for Pain, Acute Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03714620Sub-dissociative Dose Ketamine Dosing Study
NCT02817477Intranasal Ketamine for Acute Traumatic Pain